CB Scientific, Inc. Announces Voluntary Delisting from OTCQB Venture Market

CB Scientific, Inc. announces its voluntary delisting from the OTCQB Venture Market to preserve capital for future business growth. The company's common shares will continue trading on the OTC Pink Open Market.

CB Scientific, Inc. Announces Uplist to the OTCQB Venture Market

Shareholders to benefit from greater transparency and improved liquidity on OTCQB

CB Scientific, Inc. Concludes its Annual Audit with MaloneBailey, LLP

Achieving major milestone squarely positions the Company for uplisting to the OTCQB® Venture Market

Announcing Intent to Convene a Special Meeting of the Stockholders

Agenda to include matters necessary to better position the company for anticipated growth and development.

Application Filed to Uplist to the OTCQB Venture Market

Upgraded listing would provide increased transparency and enhanced trading efficiency.

Announcing The Addition of Brooke Martellaro as Chief Financial Officer

Seasoned finance executive and business leader to add significant incremental competencies to the Company’s executive management team.

Paul Danner Appointed As Chairman

The addition marks the first in a series of executive leadership enhancements intended to position CBSC for accelerated success.

Announcing the Engagement of MaloneBailey, LLP

CB Scientific, Inc (CBSC) begins independent financial audit through MaloneBailey LLP

How can we help you?

Get our news in your inbox!

Join our newsletter and we will send our news directly to you.